Year: 2024
Type: editorial
Abstract: In the evolving landscape of bladder cancer (BCa) immunotherapy, this commentary offers a critical and timely reflection on a recent review that we published previously on targeting innate lymphoid cells (ILCs) in BCa.
Source: Journal of Cancer Immunology
Authors: Zaineb Hassouneh, Gang Huang, Nu Zhang, Manjeet Rao, Neelam Mukherjee
Language: English
Topic: IL-33, ST2, and ILC Pathways
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: hybrid
Award: G1205163145
OpenAlex ID: W4403156039
